Company Overview
About Saama Analytics
Saama Analytics is the leading AI-driven clinical analytics and data management platform for the life sciences industry, positioning itself as the "#1 in AI Clinical Analytics" based on customer adoption across major pharmaceutical and biotechnology companies. Founded and headquartered in the United States, Saama's Life Science Analytics Cloud (LSAC) platform accelerates clinical trial execution by automating data processing, quality checking, safety signal detection, and regulatory submission preparation — tasks that traditionally require significant manual effort from biostatisticians, data managers, and clinical programmers.
Business Model & Competitive Advantage
In May 2025, Carlyle Group and leading healthcare-focused venture funds announced a strategic growth investment of up to $430 million in Saama, bringing total funding raised to over $507 million. This capital positions Saama to expand its AI capabilities, scale enterprise sales, and deepen integrations with clinical data platforms. Over 50 biotech companies actively use LSAC across more than 1,500 studies, and Saama counts many of the world's top-20 pharmaceutical companies among its clients.
Competitive Landscape 2025–2026
In September 2025, Saama launched the industry's first modular Clinical AI Agents — adaptive AI components that sponsors can deploy across study start through regulatory submission, enabling rapid innovation on existing platform investments. The company's AI agents address persistent bottlenecks in clinical development: data cleaning, coding and mapping, safety narrative generation, and operational metrics reporting. Saama competes with Medidata (Dassault Systèmes), Veeva Vault Clinical, and Oracle Health Sciences, but differentiates through AI-native architecture and focus on clinical data science automation.
Key Differentiators
Market Leader
Saama Analytics is recognized as a market leader in the Life Sciences & BioTech sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Compare Saama Analytics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Saama Analytics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Saama Analytics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Saama Analytics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →